Boxer Capital’s Enliven Therapeutics ELVN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-671,358
| Closed | -$17.1M | – | 14 |
|
|
2024
Q3 | $17.1M | Hold |
671,358
| – | – | 0.84% | 34 |
|
|
2024
Q2 | $15.7M | Hold |
671,358
| – | – | 0.83% | 34 |
|
|
2024
Q1 | $11.8M | Buy |
671,358
+25,300
| +4% | +$445K | 0.58% | 41 |
|
|
2023
Q4 | $8.94M | Hold |
646,058
| – | – | 0.45% | 36 |
|
|
2023
Q3 | $8.83M | Sell |
646,058
-64,586
| -9% | -$882K | 0.47% | 46 |
|
|
2023
Q2 | $14.5M | Hold |
710,644
| – | – | 0.67% | 40 |
|
|
2023
Q1 | $15.6M | Buy |
+710,644
| New | +$15.6M | 0.76% | 38 |
|